Literature DB >> 3485945

The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.

T D Bigby, D Margolskee, J L Curtis, P F Michael, D Sheppard, W K Hadley, P C Hopewell.   

Abstract

Thirty-two patients with or suspected of having the acquired immunodeficiency syndrome were evaluated for opportunistic lung infection using examination of sputum induced by inhalation of 3% saline. The specimens obtained were stained with Giemsa stain and examined for Pneumocystis carinii. Smears of sputum were also appropriately stained and examined for acid-fast organisms and fungi, as well as cultured for these organisms. Patients whose sputum did not contain P. carinii had bronchoscopy within 24 h of sputum induction. Twenty-five of the 32 patients were ultimately determined to have P. carinii pneumonia. Of these, 14 were detected by examination of sputum (sensitivity, 56%). Of 18 patients whose sputum did not contain P. carinii, 11 had the organism detected in specimens obtained by bronchoscopy (negative predictive value, 39%). There were no clinical features that identified patients more likely to have a positive sputum examination. No additional treatable lung pathogens appeared to be missed by sputum examination. In this select population, examination of induced sputum establishes the diagnosis of P. carinii pneumonia in a significant proportion of patients, thereby decreasing the need for more invasive procedures.

Entities:  

Mesh:

Year:  1986        PMID: 3485945     DOI: 10.1164/arrd.1986.133.4.515

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  40 in total

1.  Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol.

Authors:  Cristina Danés; Julián González-Martín; Tomàs Pumarola; Ana Rañó; Natividad Benito; Antoni Torres; Asunción Moreno; Montserrat Rovira; Jorge Puig de la Bellacasa
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

3.  Fulminant bronchopulmonary Kaposi's sarcoma.

Authors:  P French; M A Johnson; L Michaels; R F Miller
Journal:  Genitourin Med       Date:  1992-02

4.  Improved detection of Pneumocystis carinii by an immunofluorescence technique using monoclonal antibodies.

Authors:  M Orholm; W Holten-Andersen; J D Lundgren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

5.  Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus.

Authors:  C M Parry; H M Evans; N J Beeching
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

Review 6.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

7.  Clinical and bronchoscopic diagnosis of suspected pneumonia related to AIDS.

Authors:  A L Pozniak; K T Tung; C R Swinburn; S Tovey; S J Semple; N M Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

8.  Optimal use of the cytocentrifuge for recovery and diagnosis of Pneumocystis carinii in bronchoalveolar lavage and sputum specimens.

Authors:  V J Gill; N A Nelson; F Stock; G Evans
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

9.  Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

Authors:  J Mills; G Leoung; I Medina; P C Hopewell; W T Hughes; C Wofsy
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 10.  Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Authors:  K A Freedberg; A N Tosteson; D J Cotton; L Goldman
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.